Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
Ma H, Wu Z, Peng J, Li Y, Huang H, Liao Y, Zhou M, Sun L, Huang N, Shi M, Bin J, Liao Y, Rao J, Wang L, Liao W.
Ma H, et al. Among authors: zhou m.
Int J Cancer. 2018 Jun 15;142(12):2578-2588. doi: 10.1002/ijc.31274. Epub 2018 Feb 9.
Int J Cancer. 2018.
PMID: 29363109